Accreditation Statement for Joint Provider Activities:
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of The Medical College of Wisconsin and Chronic Pain Partner. The Medical College of Wisconsin is accredited by the ACCME to provide continuing medical education for physicians.
 
AMA Credit Designation Statement:
The Medical College of Wisconsin designates this Enduring Material for a maximum of 1 AMA PRA Category 1 Credit(s)™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Hours of Participation for Allied Health Care Professionals
The Medical College of Wisconsin designates this activity for up to 1 hours of participation for continuing education for allied health professionals. 
Session date: 
Tuesday, January 29, 2019 - 8:00am to Wednesday, January 29, 2020 - 12:45am
Location: 
Chronic Pain Partners
PO Box 229
Mason, OH 45040
United States
  • 1.00 AMA PRA Category 1 Credit(s)™
    AMA PRA Category 1 Credit(s)™
  • 1.00 Hours of Participation
    Hours of Participation credit.

Please login or register to take this course.
Program Description: 
The learner will increase their knowledge and understand basic aspects of the realm of allergic diseases and mastocytosis.  In this webinar,  the new nosology of mast cell disease, principally the key distinctions between mastocytosis and mast cell activation syndrome will be discussed. The presentation will focus on the typical clinical presentation of mast cell activation syndrome and the basic principles of treating the syndrome. The program will enable the participant to better understand these  conditions and apply appropriate techniques in their practice.
Target audience: 
Physicians
Allied Health Professionals
Learning objectives: 
  • Understand basic aspects of the realm of allergic diseases and mastocytosis.
  • Understand the new nosology of mast cell disease, principally the key distinctions between mastocytosis and mast cell activation syndrome.
  • Understand the typical clinical presentation of mast cell activation syndrome and the basic principles of treating the syndrome.
Faculty & credentials: 
Planning Committee
Linda Bluestein, MD
John Ferman

 

 

Presenter

Lawrence B. Afrin, M.D.
Armonk Integrative Medicine Armonk, NY
 
 
In accordance with the ACCME standards for Commercial Support Number 6, all in control of content disclosed any relevant financial relationships.  The following in control of content had no relevant financial relationships to disclose except the following:
 
 
 
 

CME Coordinator Contact Information

Name: 
John Ferman
Phone number: 
+1 (440) 263-5906